{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:25:26Z","timestamp":1753885526066},"reference-count":37,"publisher":"Tokyo Dental College","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bull. Tokyo Dent. Coll."],"published-print":{"date-parts":[[2001]]},"DOI":"10.2209\/tdcpublication.42.169","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T05:37:34Z","timestamp":1152250654000},"page":"169-176","source":"Crossref","is-referenced-by-count":5,"title":["Combination therapy including pentoxifylline for entero-Behcet's disease."],"prefix":"10.2209","volume":"42","author":[{"given":"TADAKAZU","family":"HISAMATSU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIROSHI","family":"KISHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDENARI","family":"FUKUYA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KATSUYOSHI","family":"MATSUOKA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOSHIO","family":"MIZUNO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIRO","family":"NISHIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1039","reference":[{"key":"1","unstructured":"1) Anaya, J.M. and Espinoza, L.R. (1995). Phosphodiesterase inhibitor pentoxifylline: An antiinflammatory\/immunomodulatory drug potentially useful in some rheumatic disease. J Rheumatol 22, 595-599."},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00338.x"},{"key":"3","unstructured":"3) Akoglu, T., Direskeneli, H. and Yazici, H. (1990). The soluble IL-2R and soluble CD-8 in Beh&ccedil;et's disease. J Rheumatol 17, 1107-1108."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bauditz, J., Haemling, J. and Ortner, M. (1997). Treatment with tumor necrosis factor inhibitor oxpentifylline dose not improve corticosteroid dependent chronic active Crohn's disease. Gut 40, 470-474.","DOI":"10.1136\/gut.40.4.470"},{"key":"5","unstructured":"5) Beh&ccedil;et, H. (1937). Uber rezidivierende aphthose, durch ein Virus verursachte Geschwure am Auge und an den Genitalien. Dermatol Wschr 105, 1152-1157."},{"key":"6","unstructured":"6) Dubost, J.J., Soubrier, M. and Ristori, J.M. (1997). An open study of the anti-TNF alpha agent pentoxifylline in the treatment of rheumatoid arthritis. Rev Rhum Engl Ed 64, 789-793."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Hamuryudan, V., Ozyazgan, Y. and Hizli, N. (1997). Azathioprine in Beh&ccedil;et's Syndrome. Arthritis Rheumatism 40, 769-774.","DOI":"10.1002\/art.1780400425"},{"key":"8","unstructured":"8) Hamzaoui, K., Hamza, M. and Ayed, K. (1990). Production of TNF-&alpha; and IL-1 in active Beh&ccedil;et's disease. J Rheumatol 17, 1428-1429."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Huizinga, Y.W., Dijkmans, B.A. and van der Velde, E.A. (1996). An open study of pentoxifylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis. Ann Rheum Dis 55, 833-836.","DOI":"10.1136\/ard.55.11.833"},{"issue":"7","key":"10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1346-8138.1994.tb01777.x","volume":"21","author":"INOUE C","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0385-2407","issn-type":"print"},{"issue":"8697","key":"11","first-page":"1078","volume":"335","year":"1990","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hassard, P.V., Binder, S.W., Nelson, V., Vasiliauskas, E.A. (2001). Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Beh&ccedil;et's disease: A case report. Gastroenterology 120, 995-999.","DOI":"10.1053\/gast.2001.22556"},{"key":"13","unstructured":"13) Katoh, K., Matsunaga, K. and Ishigatsubo, Y. (1985). Pathologically defined neuro-, vasculo-, entero-Beh&ccedil;et's disease. J Rheumatol 12, 1186-1190."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kiely, P.D., Johnson, D. and Bourke, B.E. (1998). An open study of oxpentifylline in early rheumatoid arthritis. Br J Rheumatol 37, 1033-1035.","DOI":"10.1093\/rheumatology\/37.9.1033"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kilmartin, D.J., Forrester, J.V. and Dick, A.D. (1998). Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm 6, 101-109.","DOI":"10.1076\/ocii.6.2.101.4051"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90120-3"},{"key":"17","unstructured":"17) Kotter, I., Durk, H. and Saal, J. (1996). Therapy of Beh&ccedil;et's disease. Ger J Ophthalmol 5, 92-97."},{"key":"18","unstructured":"18) Maksymowych, W.P., Avina-Zubieta, A. and Luong, M.H. (1995). An open study of pentoxifylline in the treatment of severe refractory rheumatoid arthritis. J Rheumatol 22, 625-629."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Mochizuki, M. (1997). Immunotherapy for Beh&ccedil;et's disease. Int Rev Immunol 14, 49-66.","DOI":"10.3109\/08830189709116844"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00246.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Muramatsu, M., Kotake, S. and Yoshikawa, K. (1998). The development of malignant rhabdoid tumor in a patient with Beh&ccedil;et's disease treated with ciclosporin. Graefes Arch Clin Exp Ophthalmol 236, 798-799.","DOI":"10.1007\/s004170050162"},{"issue":"2","key":"22","first-page":"262","volume":"83","year":"1994","ISSN":"http:\/\/id.crossref.org\/issn\/0019-2805","issn-type":"print"},{"issue":"3","key":"23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2567.1997.00435.x","volume":"90","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0019-2805","issn-type":"print"},{"key":"24","unstructured":"24) Niwa, Y., Miyake, S. and Sakane, T. (1982). Auto-oxidative damage in Beh&ccedil;et's disease-Endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49, 247-255."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nussenblatt, R.B., Palestine, A.G. and Chan, C.C. (1985). Cyclosporine therapy for uveitis: Long-term follow up. J Ocul Pharmacol 1, 369-382.","DOI":"10.1089\/jop.1985.1.369"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Pacor, M.L., Biasi, D. and Lunardi, C. (1994). Cyclosporin in Beh&ccedil;et's disease: Results in 16 patients after 24 months of therapy. Clin Rheumatol 13, 224-227.","DOI":"10.1007\/BF02249016"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Reimund, J.M., Dumont, S. and Muller, C.D. (1997). <i>In vitro<\/i> effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease. Gut 40, 475-480.","DOI":"10.1136\/gut.40.4.475"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sandborn, W.J. (1995). A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1, 48-63.","DOI":"10.1097\/00054725-199503000-00006"},{"key":"29","unstructured":"29) Sayek, I. , Aran, O. and Uzunalimoglu, B. (1991). Intestinal Beh&ccedil;et's disease: Surgical experience in seven cases. Hepato-gastroenterol 38, 81-83."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Scalzini, A., Barni, C., Stellini, R. and Sueri, L. (1995). Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease. Dig Dis Sci 40, 528.","DOI":"10.1007\/BF02064361"},{"issue":"4","key":"31","first-page":"520","volume":"78","year":"1993","ISSN":"http:\/\/id.crossref.org\/issn\/0019-2805","issn-type":"print"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Sloper, C.M., Powell, R.J. and Dua, H.S. (1999). Tacrolimus (FK506) in the treatment of posterior uveitis refractory to cyclosporine. Ophthalmology 106, 723-728.","DOI":"10.1016\/S0161-6420(99)90156-2"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sullu, Y., Oge, I. and Erkan, D. (1998). Cyclosporin-A therapy in severe uveitis of Beh&ccedil;et's disease. Acta Ophthalmol Scand 76, 96-99.","DOI":"10.1034\/j.1600-0420.1998.760118.x"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00354.x"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00252.x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Yasui, K., Ohta, K. and Kobayashi, M. (1996). Successful treatment of Beh&ccedil;et's disease with pentoxifylline. Ann Intern Med 124, 891-893.","DOI":"10.7326\/0003-4819-124-10-199605150-00005"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Yazici, H., Pazarli, H. and Barnes, C.G. (1990). A controlled trial of azathioprine in Beh&ccedil;et's syndrome. N Engl J Med 322, 281-285.","DOI":"10.1056\/NEJM199002013220501"}],"container-title":["The Bulletin of Tokyo Dental College"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:02:41Z","timestamp":1683504161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/tdcpublication\/42\/3\/42_3_169\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001]]}},"URL":"https:\/\/doi.org\/10.2209\/tdcpublication.42.169","relation":{},"ISSN":["0040-8891"],"issn-type":[{"value":"0040-8891","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}